医薬品・医療機器組合せの世界市場レポート 2024年

医薬品・医療機器組合せの市場規模は近年急速に拡大しています。2023年の1,203億7,000万米ドルから2024年には1,344億1,000万米ドルへと、CAGR11.7％で拡大します。過去に観察された成長は、医療技術革新の増加、慢性疾患の増加、患者中心のアプローチの採用、生物製剤の進歩、単剤療法に伴う課題、医療分野における臨床ニーズの進化などの要因によるものです。

医薬品・医療機器組合せ市場は、事故による死傷者の増加に後押しされて成長すると予想されます。事故はしばしば予期できないものであり、危害や傷害につながるものであるが、薬物と装置の併用によって効果的に管理し予防することができます。これらの組み合わせは、的を絞った医療介入を促進し、事故後の患者の安全性を高める。2021年、カナダでは1,768件の自動車による死亡事故が報告され、前年から1.3％増加しました。死傷者を管理し、重要な医療介入を行う上で薬物とデバイスの組み合わせが果たす役割は、事故関連の医療ソリューションにおいて不可欠なコンポーネントとして位置付けられ、市場の成長に寄与しています。

北米は、2023年の医薬品・医療機器組合せ市場シェアで最大の地域でした。アジア太平洋は予測期間中に最も急成長する地域となる見込みです。医薬品・医療機器組合せ市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の医薬品・医療機器組合せ市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の医薬品・医療機器組合せの市場規模実績と成長、2018～2023年
• 世界の医薬品・医療機器組合せ市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の医薬品・医療機器組合せ市場、製品別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 自動インジェクター
• マイクロニードルパッチ
• デジタルピル
• スマート吸入器
• ドラッグデリバリーヒドロゲル
• 薬剤溶出レンズ
• その他
• 世界の医薬品・医療機器組合せ市場、流通チャネル別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 直接入札
• 小売販売
• その他
• 世界の医薬品・医療機器組合せ市場、用途別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 整形外科疾患
• 呼吸器疾患
• 糖尿病
• 腫瘍学
• 心血管疾患
• その他
• 世界の医薬品・医療機器組合せ市場、エンドユーザー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• クリニック
• 病院
• 在宅医療
• 外来診療センター
• その他

第7章 地域と国の分析

• 世界の医薬品・医療機器組合せ市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界の医薬品・医療機器組合せ市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 医薬品・医療機器組合せ市場の競合情勢
• 医薬品・医療機器組合せ市場の企業プロファイル
  • The 3M Company
  • Abbott India Ltd.
  • Biotronik SE &Co. KG
  • Boston Scientific Corporation
  • CR Bard Inc

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の展望と潜在性分析

第35章 付録

Drug Device Combination Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug device combination market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug device combination? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug device combination market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product: Auto-Injector; Microneedle Patch; Digital Pill; Smart Inhaler; Drug Delivery Hydrogels; Drug-Eluting Lens; Other Products
• 2) By Distribution Channel: Direct Tender; Retails Sales; Other Distribution Channels
• 3) By Application: Orthopedic Diseases; Respiratory Diseases; Diabetes; Oncology; Cardiovascular Diseases; Other Applications
• 4) By End User: Clinics; Hospitals; Home Care Settings; Ambulatory Care Centers; Other End Users
• Companies Mentioned: The 3M Company; Abbott India Ltd.; Biotronik SE & Co. KG; Boston Scientific Corporation; C. R. Bard Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Drug-device combinations refer to therapeutic and diagnostic products that combine a medical device with a drug, facilitating localized drug administration, precise drug targeting, and personalized therapy. These combinations create a unified entity, physically and chemically, packaged together in a single package. Drug-device combinations play a crucial role in clinical development, enabling the delivery of drugs to specific locations in the body.

The primary types of drug-device combination products include auto-injectors, microneedle patches, digital pills, smart inhalers, drug delivery hydrogels, drug-eluting lenses, and other products. These products find applications in various medical fields such as orthopedic diseases, respiratory diseases, diabetes, oncology, cardiovascular diseases, among others. The end users of drug-device combination products include clinics, hospitals, home care settings, ambulatory care centers, and others. These products are distributed through direct tenders, retail sales, and other distribution channels.

The drug-device combination market research report is one of a series of new reports from The Business Research Company that provides drug-device combination market statistics, including drug-device combination industry global market size, regional shares, competitors with an drug-device combination market share, detailed drug-device combination market segments, market trends and opportunities, and any further data you may need to thrive in the drug-device combination industry. This drug-device combination market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug device combination market size has grown rapidly in recent years. It will grow from $120.37 billion in 2023 to $134.41 billion in 2024 at a compound annual growth rate (CAGR) of 11.7%. The growth observed in the historical period can be attributed to factors such as increasing medical innovation, a rise in chronic diseases, the adoption of patient-centric approaches, advances in biologics, challenges associated with monotherapy, and evolving clinical needs in the healthcare sector.

The drug device combination market size is expected to see rapid growth in the next few years. It will grow to $205.86 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The anticipated growth in the forecast period can be attributed to factors such as patient empowerment and engagement, the ongoing digitalization of healthcare, global market expansion, the emergence of novel therapies, and the shift towards value-based healthcare models. Major trends in the forecast period encompass advancements in therapeutic approaches, the management of complex diseases, the promotion of patient-centric care, continuous technological innovations, and regulatory support for healthcare initiatives.

The drug-device combination market is witnessing substantial growth driven by the increasing prevalence of chronic diseases. Chronic diseases, persisting for a year or longer and requiring ongoing medical care, include conditions like heart disease and diabetes. Drug-device combinations, encompassing therapeutic and diagnostic products, play a pivotal role in effectively treating individuals with chronic diseases. As per the World Health Organization's report, the global incidence of diabetes surpassed 420 million in 2022, with projections indicating a rise to 578 million by 2030 and 700 million by 2045. This escalating prevalence underscores the critical role of drug-device combinations in managing chronic diseases, thereby propelling the growth of the market.

The drug-device combination market is expected to experience growth propelled by an increase in casualties resulting from accidents. Accidents, often unforeseen and leading to harm or injury, can be effectively managed and prevented through the use of drug-device combinations. These combinations facilitate targeted medical interventions, enhancing patient safety in the aftermath of accidents. In 2021, Canada reported 1,768 motor vehicle fatalities, indicating a 1.3% increase from the previous year. The role of drug-device combinations in managing casualties and providing critical medical interventions positions them as integral components in accident-related healthcare solutions, thereby contributing to the growth of the market.

Technological advancement emerges as a key trend shaping the drug-device combination market. Major corporations are introducing innovative technologies to fortify their market positions. A notable example is Owen Mumford's Aidaptus auto-injector platform, launched in September 2021. This two-stage, spring-powered auto-injector incorporates self-adjusting plunger stopper sensing technology, adapting to various stopper positions and filling levels in prefilled glass syringes. Such advancements enhance the precision and efficiency of drug delivery, showcasing the industry's commitment to leveraging technology for improved healthcare outcomes.

Major companies operating in the drug-device combination market are introducing distinctive products to streamline administration processes. An exemplary launch is the G-Lasta Subcutaneous Injection 3.6 mg BodyPod by Terumo Corporation and Kyowa Kirin. This drug-device combination involves an automated injection device attached during chemotherapy, administering G-Lasta to reduce febrile neutropenia incidence. The automated system eliminates the need for additional outpatient visits, alleviating the burden on patients and exemplifying how innovative drug-device combinations contribute to enhanced treatment protocols and patient care.

In July 2021, BD, a renowned US-based medical device company, successfully acquired Zebrasci for an undisclosed sum. This strategic acquisition is poised to enhance BD's contract development service capabilities, specifically in the areas of testing and validation of combination products. By integrating Zebrasci's expertise, BD aims to strengthen its market position in the field of medical devices. Zebrasci, the acquired company, is a prominent US-based biotechnology firm specializing in the development of combination products.

Major companies operating in the drug device combination market report are The 3M Company, Abbott India Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, C. R. Bard Inc., Medtronic PLC, Amgen Inc., Ypsomed Holding AG, Micron Biomedical Inc., MetP Pharma AG, Sonceboz SA, Propeller Health B.D. Inc., Lepu Medical Technology (Beijing) Co. Ltd., Eitan Medical Ltd., Vaxess Technologies Inc., Subcuject Aps, Allergan PLC, Terumo Corporation, Stryker Corporation, Becton Dickinson and Company, Novartis AG, Zimmer Biomet Holdings Inc., MediPrint Ophthalmics, Arrow International Inc., Alcon Inc., W. L. Gore & Associates Inc., Cook Medical LLC, Pinnacle Biologics Inc., GlaxoSmithKline PLC, and Mylan N.V.

North America was the largest region in the drug-device combination market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug device combination market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug device combination market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug-device combination market consists of sales of catheter and advanced wound care products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Drug Device Combination Market Characteristics

3. Drug Device Combination Market Trends And Strategies

4. Drug Device Combination Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Drug Device Combination Market Size and Growth

• 5.1. Global Drug Device Combination Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Drug Device Combination Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Drug Device Combination Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Drug Device Combination Market Segmentation

• 6.1. Global Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Auto-Injector
• Microneedle Patch
• Digital Pill
• Smart Inhaler
• Drug Delivery Hydrogels
• Drug-Eluting Lens
• Other Products
• 6.2. Global Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Direct Tender
• Retails Sales
• Other Distribution Channels
• 6.3. Global Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Orthopedic Diseases
• Respiratory Diseases
• Diabetes
• Oncology
• Cardiovascular Diseases
• Other Applications
• 6.4. Global Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Clinics
• Hospitals
• Home Care Settings
• Ambulatory Care Centers
• Other End Users

7. Drug Device Combination Market Regional And Country Analysis

• 7.1. Global Drug Device Combination Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Drug Device Combination Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Drug Device Combination Market

• 8.1. Asia-Pacific Drug Device Combination Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Drug Device Combination Market

• 9.1. China Drug Device Combination Market Overview
• 9.2. China Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Drug Device Combination Market

• 10.1. India Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Drug Device Combination Market

• 11.1. Japan Drug Device Combination Market Overview
• 11.2. Japan Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Drug Device Combination Market

• 12.1. Australia Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Drug Device Combination Market

• 13.1. Indonesia Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Drug Device Combination Market

• 14.1. South Korea Drug Device Combination Market Overview
• 14.2. South Korea Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Drug Device Combination Market

• 15.1. Western Europe Drug Device Combination Market Overview
• 15.2. Western Europe Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Drug Device Combination Market

• 16.1. UK Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Drug Device Combination Market

• 17.1. Germany Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Drug Device Combination Market

• 18.1. France Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Drug Device Combination Market

• 19.1. Italy Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Drug Device Combination Market

• 20.1. Spain Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Drug Device Combination Market

• 21.1. Eastern Europe Drug Device Combination Market Overview
• 21.2. Eastern Europe Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Drug Device Combination Market

• 22.1. Russia Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Drug Device Combination Market

• 23.1. North America Drug Device Combination Market Overview
• 23.2. North America Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Drug Device Combination Market

• 24.1. USA Drug Device Combination Market Overview
• 24.2. USA Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Drug Device Combination Market

• 25.1. Canada Drug Device Combination Market Overview
• 25.2. Canada Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Drug Device Combination Market

• 26.1. South America Drug Device Combination Market Overview
• 26.2. South America Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Drug Device Combination Market

• 27.1. Brazil Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Drug Device Combination Market

• 28.1. Middle East Drug Device Combination Market Overview
• 28.2. Middle East Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Drug Device Combination Market

• 29.1. Africa Drug Device Combination Market Overview
• 29.2. Africa Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Drug Device Combination Market Competitive Landscape And Company Profiles

• 30.1. Drug Device Combination Market Competitive Landscape
• 30.2. Drug Device Combination Market Company Profiles
  • 30.2.1. The 3M Company
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Abbott India Ltd.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Biotronik SE & Co. KG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Boston Scientific Corporation
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. C. R. Bard Inc
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Drug Device Combination Market Competitive Benchmarking

32. Global Drug Device Combination Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Drug Device Combination Market

34. Drug Device Combination Market Future Outlook and Potential Analysis

• 34.1 Drug Device Combination Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Drug Device Combination Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Drug Device Combination Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer